Skip to main content

Switch to experimental drug after liquid biopsy detection of breast cancer recurrence improves outcomes

By WCM Newsroom  
   June 02, 2025

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.